The previous issue of HTB included information about a new campaign calling for the publication of the results (that is, full clinical study reports including negative ones) from all clinical trials -- past, present and future -- on all treatments currently being used.1
Clearly unhappy, the U.S.-based pharmaceutical membership and public relations organisation PhRMA has countered with a press statement.2
It was timely that two days later GSK announced its support for the AllTrials campaign.3
Links to other websites are current at date of posting but not maintained.
No comments have been made.